View in EDS PDF Full Text

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Saved in:
Bibliographic Details
Title: Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
Authors: Craft CS; Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School, Northwestern University and the Robert H Lurie Cancer Center of Northwestern University, Chicago, IL, USA., Romero D, Vary CP, Bergan RC
Source: Oncogene [Oncogene] 2007 Nov 08; Vol. 26 (51), pp. 7240-50. Date of Electronic Publication: 2007 May 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0950-9232 (Print) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 17496924
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Craft+CS%22">Craft CS</searchLink>; Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School, Northwestern University and the Robert H Lurie Cancer Center of Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Romero+D%22">Romero D</searchLink><br /><searchLink fieldCode="AU" term="%22Vary+CP%22">Vary CP</searchLink><br /><searchLink fieldCode="AU" term="%22Bergan+RC%22">Bergan RC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2007 Nov 08; Vol. 26 (51), pp. 7240-50. <i>Date of Electronic Publication: </i>2007 May 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0950-9232 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=17496924
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/sj.onc.1210533
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7240
    Titles:
      – TitleFull: Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Craft CS
      – PersonEntity:
          Name:
            NameFull: Romero D
      – PersonEntity:
          Name:
            NameFull: Vary CP
      – PersonEntity:
          Name:
            NameFull: Bergan RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 11
              Text: 2007 Nov 08
              Type: published
              Y: 2007
          Identifiers:
            – Type: issn-print
              Value: 0950-9232
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 51
          Titles:
            – TitleFull: Oncogene
              Type: main
ResultId 1